FDA accepts Polarean's medical imaging drug-device resubmission
(Sharecast News) - Medical imaging technology company Polarean Imaging updated the market on its investigational drug‑device combination product on Wednesday, which uses hyperpolarised '129Xenon' gas to enhance magnetic resonance imaging (MRI) in pulmonary medicine.
Read more